has_participant has participant SARS-CoV-2 N and human PPI SARS-CoV-2-human N-DDX58 colocalization, direct interaction ZW, SP, GH, YH IntAct Interaction IDs: intact:EBI-26583015|imex:IM-28618-1, intact:EBI-26583024|imex:IM-28618-3, intact:EBI-26583041|imex:IM-28618-7, intact:EBI-26583032|imex:IM-28618-5, intact:EBI-26583073|imex:IM-28618-9, intact:EBI-26583082|imex:IM-28618-11, intact:EBI-27086653|imex:IM-29216-7, intact:EBI-27086717|imex:IM-29216-13, intact:EBI-27086744|imex:IM-29216-31, intact:EBI-30814535|imex:IM-29435-47, intact:EBI-30814549|imex:IM-29435-27, intact:EBI-30850343|imex:IM-29435-53, intact:EBI-30825747|imex:IM-29435-29, intact:EBI-30850736|imex:IM-29435-37, intact:EBI-30850785|imex:IM-29435-19 imex:IM-28618|pubmed:33396605, pubmed:34471099|imex:IM-29216, imex:IM-29435|pubmed:35075101 colocalization, direct interaction (MI:0403, MI:0407) A SARS-CoV-2 N and human PPI that has an interactor of N from SARS-CoV-2 and another interactor of DDX58 from human. anti tag coimmunoprecipitation, confocal microscopy, anti bait coimmunoprecipitation (MI:0007, MI:0663, MI:0006) antiviral innate immune response receptor RIG-I (human) nucleoprotein (SARS-CoV-2)